Trevi Therapeutics, Inc.TRVINASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank89
3Y CAGR-18.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-18.1%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202538.30%
2024-62.07%
202335.56%
202269.80%
202117.68%
2020-23.97%
201936.24%
2018-60.14%
2017-107.25%
20160.00%